These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1091 related articles for article (PubMed ID: 28341421)

  • 81. Field cancerisation in colorectal cancer: a new frontier or pastures past?
    Patel A; Tripathi G; Gopalakrishnan K; Williams N; Arasaradnam RP
    World J Gastroenterol; 2015 Apr; 21(13):3763-72. PubMed ID: 25852261
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Lung adenocarcinomas without driver genes converge to common adaptive strategies through diverse genetic, epigenetic, and niche construction evolutionary pathways.
    Gatenby RA; Luddy KA; Teer JK; Berglund A; Freischel AR; Carr RM; Lam AE; Pienta KJ; Amend SR; Austin RH; Hammarlund EU; Cleveland JL; Tsai KY; Brown JS
    Med Oncol; 2024 May; 41(6):135. PubMed ID: 38704802
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Evolvability-enhancing mutations in the fitness landscapes of an RNA and a protein.
    Wagner A
    Nat Commun; 2023 Jun; 14(1):3624. PubMed ID: 37336901
    [TBL] [Abstract][Full Text] [Related]  

  • 84. microRNAs in the Malignant Transformation Process.
    Sarver AE; Li L; Kartha RV; Subramanian S
    Adv Exp Med Biol; 2015; 889():1-21. PubMed ID: 26658993
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Declining cellular fitness with age promotes cancer initiation by selecting for adaptive oncogenic mutations.
    Marusyk A; DeGregori J
    Biochim Biophys Acta; 2008 Jan; 1785(1):1-11. PubMed ID: 17980163
    [TBL] [Abstract][Full Text] [Related]  

  • 86. From Colitis to Cancer: An Evolutionary Trajectory That Merges Maths and Biology.
    Al Bakir I; Curtius K; Graham TA
    Front Immunol; 2018; 9():2368. PubMed ID: 30386335
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Tumour heterogeneity and the evolutionary trade-offs of cancer.
    Hausser J; Alon U
    Nat Rev Cancer; 2020 Apr; 20(4):247-257. PubMed ID: 32094544
    [TBL] [Abstract][Full Text] [Related]  

  • 88. SEECancer: a resource for somatic events in evolution of cancer genome.
    Zhang H; Luo S; Zhang X; Liao J; Quan F; Zhao E; Zhou C; Yu F; Yin W; Zhang Y; Xiao Y; Li X
    Nucleic Acids Res; 2018 Jan; 46(D1):D1018-D1026. PubMed ID: 29069402
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Generation of phenotypic diversity and progression in metastatic tumor cells.
    Nicolson GL
    Cancer Metastasis Rev; 1984; 3(1):25-42. PubMed ID: 6370418
    [TBL] [Abstract][Full Text] [Related]  

  • 90. CRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1-Prkaca Gene Fusion Is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma.
    Engelholm LH; Riaz A; Serra D; Dagnæs-Hansen F; Johansen JV; Santoni-Rugiu E; Hansen SH; Niola F; Frödin M
    Gastroenterology; 2017 Dec; 153(6):1662-1673.e10. PubMed ID: 28923495
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A compendium of mutational cancer driver genes.
    Martínez-Jiménez F; Muiños F; Sentís I; Deu-Pons J; Reyes-Salazar I; Arnedo-Pac C; Mularoni L; Pich O; Bonet J; Kranas H; Gonzalez-Perez A; Lopez-Bigas N
    Nat Rev Cancer; 2020 Oct; 20(10):555-572. PubMed ID: 32778778
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Aging-associated changes in hematopoiesis and leukemogenesis: what's the connection?
    Henry CJ; Marusyk A; DeGregori J
    Aging (Albany NY); 2011 Jun; 3(6):643-56. PubMed ID: 21765201
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Ultimate Precision: Targeting Cancer but Not Normal Self-replication.
    Velcheti V; Schrump D; Saunthararajah Y
    Am Soc Clin Oncol Educ Book; 2018 May; 38():950-963. PubMed ID: 30231326
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Understanding the Cause and Consequence of Tumor Heterogeneity.
    Khatib S; Pomyen Y; Dang H; Wang XW
    Trends Cancer; 2020 Apr; 6(4):267-271. PubMed ID: 32209440
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Measuring the distribution of fitness effects in somatic evolution by combining clonal dynamics with dN/dS ratios.
    Williams MJ; Zapata L; Werner B; Barnes CP; Sottoriva A; Graham TA
    Elife; 2020 Mar; 9():. PubMed ID: 32223898
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Perturbation-Driven Entropy as a Source of Cancer Cell Heterogeneity.
    Nijman SMB
    Trends Cancer; 2020 Jun; 6(6):454-461. PubMed ID: 32460001
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Inferring mutational timing and reconstructing tumour evolutionary histories.
    Turajlic S; McGranahan N; Swanton C
    Biochim Biophys Acta; 2015 Apr; 1855(2):264-75. PubMed ID: 25827356
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Modeling a cancerous tumor development in a virtual patient suffering from a depressed state of mind: Simulation of somatic evolution with a customized genetic algorithm.
    Lahoz-Beltra R; Rodriguez RJ
    Biosystems; 2020 Dec; 198():104261. PubMed ID: 33002528
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Constraints in cancer evolution.
    Venkatesan S; Birkbak NJ; Swanton C
    Biochem Soc Trans; 2017 Feb; 45(1):1-13. PubMed ID: 28202655
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Passenger mutations can accelerate tumour suppressor gene inactivation in cancer evolution.
    Wodarz D; Newell AC; Komarova NL
    J R Soc Interface; 2018 Jun; 15(143):. PubMed ID: 29875280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 55.